BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9815802)

  • 21. Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells.
    Saimoto A; Saito S; Murai M
    Jpn J Cancer Res; 1999 Feb; 90(2):233-9. PubMed ID: 10189895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
    Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
    Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy.
    Ogawa O; Iinuma M; Sato K; Sasaki R; Shimoda N; Satoh S; Kato T
    Urol Res; 1999 Aug; 27(4):291-6. PubMed ID: 10460902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.
    Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J
    Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
    Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.
    Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ
    Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
    Theodorescu D; Frierson HF; Sikes RA
    J Urol; 1999 May; 161(5):1442-8. PubMed ID: 10210369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
    Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of prostate-specific membrane antigen in peripheral blood leukocytes.
    Lintula S; Stenman UH
    J Urol; 1997 May; 157(5):1969-72. PubMed ID: 9112573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?
    Adsan O; Cecchini MG; Bisoffi M; Wetterwald A; Klima I; Danuser HJ; Studer UE; Thalmann GN
    BJU Int; 2002 Oct; 90(6):579-85. PubMed ID: 12230621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
    Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
    J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.
    Katz AE; Olsson CA; Raffo AJ; Cama C; Perlman H; Seaman E; O'Toole KM; McMahon D; Benson MC; Buttyan R
    Urology; 1994 Jun; 43(6):765-75. PubMed ID: 7515202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
    de Cremoux P; Ravery V; Podgorniak MP; Chevillard S; Toublanc M; Thiounn N; Tatoud R; Delmas V; Calvo T; Boccon-Gibod L
    Eur Urol; 1997; 32(1):69-74. PubMed ID: 9266235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
    Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T
    Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of prostate cells in ejaculate and urethral washings in men with suspected prostate cancer.
    Clements JA; Rohde P; Allen V; Hyland VJ; Samaratunga ML; Tilley WD; Lavin MF; Gardiner RA
    J Urol; 1999 Apr; 161(4):1337-43. PubMed ID: 10081904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.